Hutchmed China Ltd (HCM) Hedge Fund Ownership (Q2 2026)

Q: Is it too late to buy Hutchmed China Ltd (HCM) following the 2026 Q2 hedge fund 13F filings?

As of today, HCM has moved +15.5% since the 2026 Q2 13F filing date (August 14, 2026), compared to +2.4% for the XLV sector ETF — an outperformance of +13.1%. Since the quarter end (June 30, 2026), HCM gained +30.9% vs +8.1% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Hutchmed China Ltd (HCM)

56 + Investors. Track Smart Money conviction in HCM. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — HCM

Based on 56 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q

For 2 consecutive quarters, more hedge funds added HCM than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

📊

High ownership — 82% of 3.0Y peak

82% of all-time peak

56 funds currently hold this stock — 82% of the 3.0-year high of 68 funds (reached 2023 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.

📉

Outflows — 8% fewer funds vs a year ago

fund count last 6Q

5 fewer hedge funds hold HCM compared to a year ago (-8% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.

🟠

More sellers than buyers — 48% buying

24 buying26 selling

Last quarter: 26 funds reduced or exited vs 24 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

➡️

Steady new buyers — ~10 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 3 → 3 → 10 → 10. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔒

64% of holders stayed for 2+ years

■ 64% conviction (2yr+) ■ 14% medium ■ 21% new

36 out of 56 hedge funds have held HCM for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💎

Buying through price weakness — shares +5%, value -20%

Value

-20%

+4%

Last quarter: funds added +5% more shares while total portfolio value only changed -20%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

➡️

Steady discovery — ~10 new funds/quarter

9 → 3 → 3 → 10 → 10 new funds/Q

New funds entering each quarter: 3 → 3 → 10 → 10. Consistent flow of new institutional buyers without clear acceleration or slowdown.

🏛️

Veteran-anchored — 66% veterans vs 23% newcomers

■ 66% veterans ■ 11% 1-2yr ■ 23% new

Entry-cohort mix of 56 holders: 37 (66%) are 2+ year veterans, 6 entered 1–2 years ago, and 13 (23%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

🏆

Elite ownership — 50% AUM from top-100 funds

50% from top-100 AUM funds

21 of 56 holders are among the 100 largest funds by AUM, controlling 50% of total institutional value in HCM. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

2.7

out of 10

Low Exit Risk

Exit risk score 2.7/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	56	51	9.8%
13F Shares	4M	4M	4.91%
Total Value	$51M	$64M	-20.0%
New Positions	10	10	-
Increased Positions	14	14	-
Closed Positions	5	6	-1
Reduced Positions	21	17	+4
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

9.8%

13F Shares

4.91%

Total Value

$51M

$64M

-20.0%

New Positions

Increased Positions

Closed Positions

-1

Reduced Positions

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

56 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in HCM. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 HCM holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	XY Capital Ltd	1.08%	104,130	$1.1M
2	AIA Group Ltd	0.04%	291,229	$3.1M
3	M&G Plc	0.01%	242,791	$2.7M
4	Crossmark Global Holdings, Inc.	0.01%	84,915	$914K
5	Schroder Investment Management Group	0.01%	1,477,494	$15.8M
6	Allianz Asset Management GmbH	0.01%	837,475	$12.5M
7	StoneX Group Inc.	0.01%	18,262	$214K
8	Silver Grove Financial Group, Inc.	0.00%	583	$6K
9	Vident Advisory, LLC	0.00%	26,584	$286K
10	Renaissance Technologies LLC	0.00%	130,200	$1.4M
11	Summit Trail Advisors, LLC	0.00%	13,090	$141K
12	XTX Topco Ltd	0.00%	12,409	$134K
13	Bell Investment Advisors, Inc	0.00%	1,015	$11K
14	Cornerstone Financial Management LLC	0.00%	134	$1K
15	Blue Trust, Inc.	0.00%	7,708	$83K
16	Amundi	0.00%	204,385	$2.2M
17	Two Sigma Investments, LP	0.00%	63,248	$681K
18	BNP Paribas Financial Markets	0.00%	104,425	$1.1M
19	Fiduciary Financial Advisors	0.00%	291	$3K
20	North Star Investment Management Corp.	0.00%	379	$4K
21	Physician Wealth Advisors, Inc.	0.00%	144	$2K
22	Jane Street Group, LLC	0.00%	194,472	$2.1M
23	Pinnacle Wealth Planning Services, Inc.	0.00%	124	$1K
24	Mariner, LLC	0.00%	10,656	$115K
25	Millennium Management LLC	0.00%	26,420	$284K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Hutchmed China Ltd (HCM)

What does the Smart Money Trend signal show for HCM?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added HCM than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for HCM?

More sellers than buyers — 48% buying: Last quarter: 26 funds reduced or exited vs 24 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for HCM holders?

Elite ownership — 50% AUM from top-100 funds: 21 of 56 holders are among the 100 largest funds by AUM, controlling 50% of total institutional value in HCM. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held HCM?

64% of holders stayed for 2+ years: 36 out of 56 hedge funds have held HCM for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Hutchmed China Ltd (HCM) following the 2026 Q2 hedge fund 13F filings?

As of today, HCM has moved +15.5% since the 2026 Q2 13F filing date (August 14, 2026), compared to +2.4% for the XLV sector ETF — an outperformance of +13.1%. Since the quarter end (June 30, 2026), HCM has gained +30.9% vs +8.1% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Hutchmed China Ltd (HCM)

Smart Money Signals — HCM

Buying streak — 2 quarters in a row

High ownership — 82% of 3.0Y peak

Outflows — 8% fewer funds vs a year ago

More sellers than buyers — 48% buying

Steady new buyers — ~10 new funds per quarter

64% of holders stayed for 2+ years

Buying through price weakness — shares +5%, value -20%

Steady discovery — ~10 new funds/quarter

Veteran-anchored — 66% veterans vs 23% newcomers

Elite ownership — 50% AUM from top-100 funds

Institutional Sentiment Summary — HCM

Hedge Fund Ownership: HCM

Market Analysis: HCM

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: HCM

Is It Too Late to Buy Hutchmed China Ltd (HCM) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: HCM

Statistics: HCM

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Hutchmed China Ltd (HCM)

Welcome to 13Foresight!